Advertisement

Topics

Hemosol Corp. Company Profile

10:05 EDT 24th September 2017 | BioPortfolio

Hemosol is a biopharmaceutical company focused on the development and manufacturing of biologics, particularly blood-related proteins. Hemosol has a broad range of novel therapeutic products in development, including oxygen therapeutics and protein-based therapeutics to treat certain infectious diseases, cancers and anemia.

Location

2585 Meadowpine Blvd
Mississauga
Ontario
L5N 8H9
Canada

Contact

Phone: 905-286-6200
Fax: 905-286-6300.
Email: lhartwell@hemosol.com


News Articles [43 Associated News Articles listed on BioPortfolio]

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...

GTX Corp Receives Military Contract

LOS ANGELES, CALIFORNIA , Sept. 20, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive ...

GTX Corp Partners with ORBCOMM to Enable GPS SmartSoles on the Verizon Network

LOS ANGELES, CALIFORNIA , Sept. 12, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive te...

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, tod...

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today...

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will presen...

Orkla Food Ingredients signs licence agreement with Renaissance BioScience Corp. for Acrylamide-Reducing Yeast Technology

OSLO, Norway and VANCOUVER, British Columbia, May 23, 2017 (GLOBE NEWSWIRE) -- Orkla Food Ingredients, a business area of Orkla ASA (OSE:ORK) has signed a licence agreement with Renaissance BioSc...

pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11th

WATERTOWN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye dise...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.

Electric conductivity in plasma is the balance between oxidized and reduced molecules (static Oxidation-Reduction Potential, sORP) and the amount of readily oxidizable molecules (capacity ORP, cORP). ...

Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.

Spanidis, Y, Stagos, D, Orfanou, M, Goutzourelas, N, Bar-or, D, Spandidos, D, and Kouretas, D. Variations in oxidative stress levels in 3 days follow-up in ultramarathon mountain race athletes. J Stre...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [39 Associated Companies listed on BioPortfolio]

Hemosol Corp.

Hemosol is a biopharmaceutical company focused on the development and manufacturing of biologics, particularly blood-related proteins. Hemosol has a broad range of novel therapeutic products in develo...

Hemasol

Hemosol BioPharma Inc. is a privately held specialty biopharmaceutical company wholly owned by Catalyst Fund Limited Partnership II. The Company is focused primarily on the development and manufactur...

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

Precision Engineered Products LLC

More Information about "Hemosol Corp." on BioPortfolio

We have published hundreds of Hemosol Corp. news stories on BioPortfolio along with dozens of Hemosol Corp. Clinical Trials and PubMed Articles about Hemosol Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hemosol Corp. Companies in our database. You can also find out about relevant Hemosol Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record